Protease-Sensitive Conformers in Creutzfeldt-Jakob Disease Indicate Disease Progression
Author Information
Author(s): Kim Chae, Haldiman Tracy, Cohen Yvonne, Chen Wei, Blevins Janis, Sy Man-Sun, Cohen Mark, Safar Jiri G.
Primary Institution: Case Western Reserve University
Hypothesis
The study investigates the molecular mechanism responsible for the broad phenotypic variability of sporadic Creutzfeldt-Jakob disease (sCJD) by analyzing the conformational characteristics of prion proteins.
Conclusion
The concentration and stability of protease-sensitive conformers of PrPSc correlate with the progression rate of sporadic Creutzfeldt-Jakob disease.
Supporting Evidence
- In sCJD cases homozygous for methionine or valine at codon 129, the concentration and stability of protease-sensitive conformers of PrPSc correlated with disease progression.
- Patients with Type 1 PrPSc had a significantly shorter disease duration than those with Type 2 PrPSc.
- Up to 90% of the pathogenic prion protein in sCJD was found to be protease-sensitive.
Takeaway
This study found that certain forms of a protein related to a brain disease can tell us how fast the disease is getting worse.
Methodology
The study used a conformation-dependent immunoassay (CDI) to analyze the prion protein structures in brain samples from patients with sCJD.
Limitations
The study only included patients homozygous for codon 129 of the PRNP gene, which may limit the generalizability of the findings.
Participant Demographics
Patients were homozygous for polymorphisms in the PRNP gene, with a mix of Type 1 and Type 2 western blot patterns.
Statistical Information
P-Value
p=0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website